GlassScriptPhysician profile
Benjamin L Lancaster
NPI 1134649239
$5,262.81
in general payments reported to CMS, 2019-2025
10 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,519 · 2020: $217 · 2021: $261 · 2022: $1,494 · 2023: $240 · 2024: $339 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,196.10 | 2019-2022 | |
| Alon Medical Technology | $1,200.00 | 2022 | |
| Bioventus LLC | $549.86 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System, L360 Thigh System |
| Depuy Synthes Sales INC. | $513.14 | 2019-2022 | |
| Stryker Corporation | $417.99 | 2019-2025 | Mako, Triathlon, Restoration |
| Zimmer Biomet Holdings, INC. | $297.04 | 2019-2021 | |
| Orthofix Medical, INC. | $34.65 | 2023-2025 | Physio-Stim |
| Orthalign INC | $25.27 | 2023 | Orthalign Plus |
| Sanara Medtech INC. | $15.12 | 2023 | Celleraterx |
| Vericel Corporation | $13.64 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lancaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.